The six deadliest cancers are lung, oesophageal, brain, stomach, liver and pancreatic. Yet despite accounting for 40% of all cancer deaths, only 16.6% of research funding is invested in increasing survival rates.
At Holyrood I spoke to people who had lost family members to these less survivable cancers, including one person who had lost both sisters in their fifties.
It’s clear that if survival rates in hard to treat cancers is to increase, so must overall funding and the proportion of cancer research funding dedicated to them.
